Syngeneic models provide a platform of complete immune system to test the efficacy of immune-oncology drugs and treatment. About 12 mouse tumor models can be selected to test various checkpoint inhibitors or other immune-oncological treatments. In addition to providing standard drug response curves, FACS, ELISA and IHC analysis of TILs are also available.
|LL/2||Lewis lung carcinoma|
|Hepa 1-6||Hepatocellular carcinoma|
|266.6||Pancreatic acinar neoplasm|
|MBT-2||Bladder transitional cell carcinoma|
|MC38-OVA||Colon carcinoma (Engineered)|
|MC38-hPDL1||Colon carcinoma (Humanized)|